Signs and Symptoms of QT Prolongation
QT prolongation itself is typically asymptomatic and detected only on ECG, but when it triggers ventricular arrhythmias—particularly torsades de pointes—patients present with palpitations, lightheadedness, syncope, dyspnea, chest pain, or cardiac arrest. 1
Clinical Presentation Algorithm
Asymptomatic Phase (Most Common)
- QT prolongation is usually discovered incidentally on routine ECG or monitoring, as the prolonged repolarization itself produces no symptoms 2, 3
- Patients remain completely asymptomatic until an arrhythmic event occurs 4
Symptomatic Arrhythmic Events
When QT prolongation triggers torsades de pointes or other ventricular arrhythmias, patients develop:
Cardiac symptoms:
- Palpitations (either skipped beats, extra beats, or sustained palpitations) 1
- Chest pain 1
- Shortness of breath or dyspnea 1
Neurological symptoms from decreased cerebral perfusion:
- Dizziness or lightheadedness 1, 2
- Near syncope or syncope (loss of consciousness) 1
- Seizure-like activity (arrhythmic syncope is frequently misdiagnosed as epilepsy) 1
Life-threatening presentations:
- Cardiac arrest 1
- Sudden cardiac death 1
- Unexplained motor vehicle crashes (from syncope while driving) 1
Critical Warning Signs Requiring Immediate Evaluation
Any patient experiencing palpitations, lightheadedness, dizziness, or syncope while taking QT-prolonging medications should go directly to the emergency room, as these symptoms may herald torsades de pointes 2, 3
High-Risk ECG Findings That Predict Imminent Arrhythmia
Patients with QT prolongation who develop these ECG patterns are at immediate risk of torsades de pointes:
- Sudden bradycardia or long pauses (especially compensatory pauses after ventricular ectopy) 1
- Enhanced U waves 1
- T wave alternans 1
- Polymorphic ventricular premature beats, couplets, or nonsustained polymorphic ventricular tachycardia 1
- Short-long-short cycle length sequences preceding arrhythmia 1
Physical Examination Findings
The physical examination during asymptomatic QT prolongation is typically normal, but during arrhythmic events clinicians should assess:
- Heart rate and regularity, blood pressure (may show tachycardia, irregular rhythm, or hypotension during arrhythmia) 1
- Jugular venous pressure (elevated in heart failure, which increases arrhythmia risk) 1
- Cardiac murmurs (structural heart disease increases risk) 1
- Peripheral pulses and bruits 1
- Edema (suggests heart failure) 1
- Sternotomy scars (prior cardiac surgery) 1
Context-Specific Presentations
In Patients With Heart Disease
Symptoms may be more severe and the risk of sudden cardiac death is substantially elevated, particularly in those with ischemic heart disease, heart failure with reduced ejection fraction, or left ventricular hypertrophy 1, 5
In Patients With Electrolyte Imbalances
Hypokalemia and hypomagnesemia dramatically increase the risk of torsades de pointes even with modest QT prolongation 1, 2. Patients may present with:
- Symptoms from the underlying cause (nausea, vomiting, diarrhea causing electrolyte losses) 6, 5
- Arrhythmic events triggered by the electrolyte disturbance rather than extreme QT prolongation 1, 2
Precipitating Factors for Symptomatic Events
Exercise or emotional stress frequently triggers arrhythmic events in patients with QT prolongation, particularly those with congenital long QT syndrome 1
Common Pitfalls in Recognition
The severity of symptoms does not necessarily reflect the extent of QT prolongation or the potential risk of sudden cardiac death 1. A patient with marked QT prolongation may remain asymptomatic, while another with moderate prolongation may experience cardiac arrest.
Palpitations may correlate with ventricular arrhythmias but are frequently reported during normal rhythm, making symptom correlation with actual arrhythmic events challenging 1
Syncope from ventricular arrhythmias is commonly misdiagnosed as epilepsy, particularly in younger patients, delaying appropriate cardiac evaluation 1, 4
Risk Stratification Based on Presentation
Patients presenting with syncope for which ventricular arrhythmia is documented or thought to be a likely cause should be hospitalized for evaluation, monitoring, and management (Class I recommendation, Level B-NR evidence) 1
More dramatic symptoms, particularly in patients with known or discovered structural or electrical heart disease, should prompt focused investigation for possible association with ventricular arrhythmias 1